DYNE THERAPEUTICS INC

29.86

07-November-24 13:37:07

15 minutes delayed

Stocks

+0.05

+0.17%

Today's range

29.76 - 30.97

ISIN

N/A

Source

NASDAQ

Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights

04 Mar 2021 07:35:00 By Nasdaq GlobeNewswire
Dyne Therapeutics Appoints Wildon Farwell, M.D., MPH, as Chief Medical Officer

04 Mar 2021 07:25:00 By Nasdaq GlobeNewswire
Dyne Therapeutics Appoints Ashish Dugar, Ph.D., MBA, Senior Vice President, Global Head of Medical Affairs

08 Feb 2021 07:30:00 By Nasdaq GlobeNewswire
Dyne Therapeutics Announces Pricing of $168 Million Public Offering

20 Jan 2021 20:05:29 By Nasdaq GlobeNewswire
Dyne Therapeutics Myotonic Dystrophy Type 1 Program Achieves Robust RNA Knock Down of Toxic Human Nuclear DMPK in Preclinical Study

10 Jan 2021 15:00:00 By Nasdaq GlobeNewswire
Dyne Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

05 Jan 2021 07:30:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
5
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.